Cargando…
Optimal Chemotherapy for Leukemia: A Model-Based Strategy for Individualized Treatment
Acute Lymphoblastic Leukemia, commonly known as ALL, is a predominant form of cancer during childhood. With the advent of modern healthcare support, the 5-year survival rate has been impressive in the recent past. However, long-term ALL survivors embattle several treatment-related medical and socio-...
Autores principales: | Jayachandran, Devaraj, Rundell, Ann E., Hannemann, Robert E., Vik, Terry A., Ramkrishna, Doraiswami |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195683/ https://www.ncbi.nlm.nih.gov/pubmed/25310465 http://dx.doi.org/10.1371/journal.pone.0109623 |
Ejemplares similares
-
Model-Based Individualized Treatment of Chemotherapeutics: Bayesian Population Modeling and Dose Optimization
por: Jayachandran, Devaraj, et al.
Publicado: (2015) -
A model to rate strategies for managing disease due to COVID-19 infection
por: Wang, Shiyan, et al.
Publicado: (2020) -
Mathematical Modeling of Hydroxyurea Therapy in Individuals with Sickle Cell Disease
por: Pandey, Akancha, et al.
Publicado: (2022) -
New “Tau-Leap”
Strategy for Accelerated Stochastic
Simulation
por: Ramkrishna, Doraiswami, et al.
Publicado: (2014) -
A Metabolomics Approach for Early Prediction of Vincristine-Induced Peripheral Neuropathy
por: Verma, Parul, et al.
Publicado: (2020)